Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-17

Clinical Trial Update: Effect of Pregabalin Gel in Controlling Cervical Dentin Hypersensitivity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pregabalin gel for cervical dentin hypersensitivity, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin Gel (pregabalin)

Snippet

Sponsor: Jesuína Lamartine Nogueira Araújo | Conditions: Dentin Sensitivity | Phase 2 | Status: NOT_YET_RECRUITING